CLC bio, a QIAGEN Company, has announced a new release of CLC Drug Discovery Workbench, an enterprise drug-design platform for medicinal and computational scientists
CLC bio has released an add-on module to CLC Genomics Workbench, which has been developed to help finish the assembly of small genomes
Version 5.5 of Molegro Virtual Docker, an integrated platform for computational drug design available for Windows, Linux and Mac OS X, has been released by CLC bio
CLC bio has released version 5.5 of its CLC Genomics Workbench desktop software, supporting a complete resequencing workflow from read mapping over variant detection to downstream analysis
CLC bio has incorporated the features from its CLC DNA Workbench, CLC RNA Workbench and CLC Protein Workbench desktop software packages into a single commercial workbench
CLC bio has revealed Genomics Gateway, a new framework for visualising, combining and analysing genome data
CLC bio has released version 2.0 of CLC Genomics Server, its enterprise platform for Next Generation Sequencing data analysis
CLC bio has released new versions of its solutions for analysing and visualising next generation sequencing data: CLC Genomics Workbench, version 3.5, and CLC Genomics Server, version 1.5.
CLC bio has released Genomics Workbench version 3.0, for analysis and visualisation of sequencing data. The cross-platform software combines expression analyses with next-generation sequencing, bridging analogue and digital gene expression
CLC bio has released its Next Generation Sequencing (NGS) solution, CLC Genomics Workbench, which incorporates cutting-edge technology and algorithms, while also supporting and integrating with the rest of a typical NGS workflow.
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
